文献
J-GLOBAL ID:201302265990580055
整理番号:13A0781806
マイクロRNA-132は乳癌腺管内癌(DCIS)の多くでダウンレギュレーションとなり,細胞増殖阻害により腫瘍抑制性に作用
MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation
著者 (40件):
LI Shuai
(Tianjin Medical Univ. Cancer Inst. and Hospital, Tianjin, CHN)
,
ZHAI Lili
(Tianjin Medical Univ. Cancer Inst. and Hospital, Tianjin, CHN)
,
GU Feng
(Tianjin Medical Univ. Cancer Inst. and Hospital, Tianjin, CHN)
,
FAN Yu
(Tianjin Medical Univ. Cancer Inst. and Hospital, Tianjin, CHN)
,
LANG Ronggang
(Tianjin Medical Univ. Cancer Inst. and Hospital, Tianjin, CHN)
,
FU Li
(Tianjin Medical Univ. Cancer Inst. and Hospital, Tianjin, CHN)
,
LI Shuai
(Tianjin Medical Univ., Tianjin, CHN)
,
MENG Huimin
(Tianjin Medical Univ., Tianjin, CHN)
,
ZHOU Feng
(Tianjin Medical Univ., Tianjin, CHN)
,
ZHAI Lili
(Tianjin Medical Univ., Tianjin, CHN)
,
ZHANG Lina
(Tianjin Medical Univ., Tianjin, CHN)
,
GU Feng
(Tianjin Medical Univ., Tianjin, CHN)
,
FAN Yu
(Tianjin Medical Univ., Tianjin, CHN)
,
LANG Ronggang
(Tianjin Medical Univ., Tianjin, CHN)
,
FU Li
(Tianjin Medical Univ., Tianjin, CHN)
,
GU Lin
(Tianjin Medical Univ., Tianjin, CHN)
,
QI Liqiang
(Tianjin Medical Univ., Tianjin, CHN)
,
LI Shuai
(Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN)
,
MENG Huimin
(Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN)
,
ZHOU Feng
(Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN)
,
ZHAI Lili
(Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN)
,
ZHANG Lina
(Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN)
,
GU Feng
(Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN)
,
FAN Yu
(Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN)
,
LANG Ronggang
(Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN)
,
FU Li
(Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN)
,
GU Lin
(Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN)
,
QI Liqiang
(Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN)
,
LI Shuai
(State Key Lab. of Breast Cancer Res., Tianjin, CHN)
,
MENG Huimin
(State Key Lab. of Breast Cancer Res., Tianjin, CHN)
,
ZHOU Feng
(State Key Lab. of Breast Cancer Res., Tianjin, CHN)
,
ZHAI Lili
(State Key Lab. of Breast Cancer Res., Tianjin, CHN)
,
ZHANG Lina
(State Key Lab. of Breast Cancer Res., Tianjin, CHN)
,
GU Feng
(State Key Lab. of Breast Cancer Res., Tianjin, CHN)
,
FAN Yu
(State Key Lab. of Breast Cancer Res., Tianjin, CHN)
,
LANG Ronggang
(State Key Lab. of Breast Cancer Res., Tianjin, CHN)
,
FU Li
(State Key Lab. of Breast Cancer Res., Tianjin, CHN)
,
GU Lin
(State Key Lab. of Breast Cancer Res., Tianjin, CHN)
,
QI Liqiang
(State Key Lab. of Breast Cancer Res., Tianjin, CHN)
,
FU Li
(2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, CHN)
資料名:
Pathology. Research and Practice
(Pathology. Research and Practice)
巻:
209
号:
3
ページ:
179-183
発行年:
2013年03月
JST資料番号:
A1139A
ISSN:
0344-0338
資料種別:
逐次刊行物 (A)
発行国:
オランダ (NLD)
言語:
英語 (EN)